LOS
ANGELES, CA -- September 9, 2020 -- InvestorsHub NewsWire --
Cannabis Global, Inc. (OTC:
CBGL) ("Cannabis Global" or the "Company"), a cannabis,
cannabinoid and hemp extract science-forward company developing
unique infusion technologies and products, today provides a recap
of the recently closed fiscal year (Aug. 31st)
and offers insight on next steps for the Company as it begins
marketing activities.
"It's been
approximately one year since we reorganized the Company toward
cannabinoid technologies and products," commented CEO, Arman
Tabatabaei. "We have made substantial progress in our
selected technology areas, and based on these innovations, we have
designed a revolutionary set of products, which are now rolling out
into the marketplace. I am pleased to offer our investors and
the industry the following summary of activities and insight into
our direction for this new fiscal year."
Licensed
Cannabis Manufacturing and Distribution – On the last day of the
Company's August 31st
fiscal year end,
the Company closed on the acquisition of an 18.8% ownership
interest in a fully licensed cannabis
manufacturing and distribution business operation located in
Lynwood, California operating under the name Natural Plant Extract
of California, Inc. ("NPE"). NPE owns a Type 7 California
Manufacturing License as well as a California Distribution license.
The Company expects that this $2,040,000 acquisition will greatly
impact the financial performance of Cannabis Global with increased
revenue and assets via its ownership stake. This acquisition
represents a strategic horizontal expansion of the Company's core
technologies beyond hemp and CBD into California's legal
recreational and medical cannabis sectors.
Technology
Innovation - During the prior fiscal year, the Company produced
multiple technological innovations, which resulted in the filing of
six provisional patent applications. The Company believes the
most significant of these are new methods to produce highly loaded
polymeric nanoparticles, powderization technologies for hemp
extract containing honey, and the single-serving tableting
technology for beverage infusion. This core technology is
used in our signature product lines: the coffee pods and cocktail
mixers.
THC-V -
Tetrahydrocannabivarian (THC-V) is a little researched exotic
cannabinoid with possible benefits relating to weight loss and
appetite suppression. During the year, the Company developed
new methods to produce nanoparticles of THC-V and other
cannabinoids filing provisional patents on both the methods and the
particles produced.
Alcohol-Replacement
Technology - During the year, the Company developed Hemp You Can
Feel technology based on powdered water-soluble preparations
developed by the Company. Marketed in cocktail mixers, the
Company believes this is the industry's first real alcohol
replacement technology. We are in the process of placing the
alcohol mixers in a major distribution company to maximize our
exposure to customers.
Distribution -
Moving into the newly commenced fiscal year, the major emphasis of
the Company is expanding distribution channels for the highly
innovative product lines. To this end, the Company has
recently begun an affiliate marketing campaign and is now offering
products on the Amazon and RXLeaf platforms. The Company
plans to also begin marketing its alcohol-free cocktail mixers on
Amazon with two cocktail mixers SKUs delivered to Amazon this
week.
Beverage Dosing
Technology – The Company continues its R&D program in the area
of tablet technology for single-serving beverages having recently
filed a provisional patent relative to these areas.
Additional filings are expected over the coming weeks.
New
Products - Based on the technology innovations developed through
the previous fiscal year, Cannabis Global has developed multiple
innovative products with coffee, Kombucha, and cocktail mixer
products currently being marketed. Additionally, the Company
is in production for both its hemp-based sweetener products and its
highly innovative THC-V tea product line.
About Cannabis
Global, Inc.
Cannabis Global,
Inc., formerly known as MCTC Holdings, Inc., is a fully audited and
reporting Company with the U.S. Securities & Exchange
Commission, trading with the stock symbol
CBGL. The Company is an emerging force in the area of
cannabinoid sciences and highly bioavailable hemp and cannabis
infusion technologies. The Company does not directly engage in the
production, distribution, or sales of any controlled substances,
including marijuana. The Company has an actively growing portfolio
of intellectual property having filed six patents in the areas of
cannabinoid delivery systems and cannabinoid polymeric
nanoparticles. The Company markets its consumer products under the
Hemp You Can Feel™ brand name. Cannabis Global launched its Project
Varin early in 2020, to develop new delivery methods for rare
cannabinoid Tetrahydrocannabivarin (THV-C) and to develop products
based on this cannabinoid.
About
Provisional Patent Filings
Under United
States patent law, a provisional application is a legal document
filed in the United States Patent and Trademark Office, that
establishes an early filing date, but does not mature into an
issued patent unless the applicant files a regular non-provisional
patent application within one year.
Forward-looking
Statements
This
news release contains "forward-looking statements" which are not
purely historical and may include any statements regarding beliefs,
plans, expectations or intentions regarding the future. Such
forward-looking statements include, among other things, the
development, costs and results of new business opportunities and
words such as "anticipate", "seek", intend", "believe", "estimate",
"expect", "project", "plan", or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Actual results could
differ from those projected in any forward-looking statements due
to numerous factors. Such factors include, among others, the
inherent uncertainties associated with new projects, the future
U.S. and global economies, the impact of competition, and the
Company's reliance on existing regulations regarding the use and
development of cannabis-based products. These forward-looking
statements are made as of the date of this news release, and we
assume no obligation to update the forward-looking statements, or
to update the reasons why actual results could differ from those
projected in the forward-looking statements. Although we believe
that any beliefs, plans, expectations and intentions contained in
this press release are reasonable, there can be no assurance that
any such beliefs, plans, expectations or intentions will prove to
be accurate. Investors should consult all of the information set
forth herein and should also refer to the risk factors disclosure
outlined in our annual report on Form 10-k, registration statements
on Form S-1, our quarterly reports on Form 10-Q and other periodic
reports filed from time-to-time with the Securities and Exchange
Commission. For more information, please visit www.sec.gov.
For
more information, please contact:
Arman
Tabatabaei
IR@cannabisglobalinc.com
+1-(310)-986-4929
Public
Relations:
Tiger
Global Marketing & Branding Agency
info@TigerGMP.com
www.TigerGMP.com
SOURCE
Cannabis Global, Inc.
Related
Links
https://hempyoucanfeel.com
Cannabis Global (PK) (USOTC:CBGL)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Cannabis Global (PK) (USOTC:CBGL)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
